All products sold on this website are for Research Use Only (RUO). Not for human or veterinary use. Not approved by the FDA for any therapeutic purpose.

>99% Purity | Same-Day Shipping | 24/7 Research Support | Free Shipping $200+

0

Product

Home > Shop > GLP3-Ret

P-RT10

GLP3-Ret

4.9

(363)

Retatrutide is a triple hormone receptor agonist targeting glp-1, gip, and glucagon receptors for research into metabolic regulation. Research applications include investigations into glucose homeostasis, weight management, appetite control, and metabolic syndrome in experimental models.

Variant Strength

Clear

1 Bottle

$85.00

2 Bottles

$80.75 (5% off)

3+ Bottles

$78.63 (7% off)

Quantity

x

15 Apl Wed - 18 Apl Wed

Free shipping protection

Overnight shipping available

We accept

Frequently Researched Together

Products commonly paired with Retatrutide for complementary research applications

Tesamorelin

Price range: $89.00 through $175.00

Growth & Secretagogue Research

4.9

(310)

KLOW (TB + BPC-157 + GHK + KPV)

Original price was: $194.00.Current price is: $159.00.

Tissue Repair Research, Dermal Research

4.9

(417)

CJC-1295 (without DAC) + IPA

Original price was: $111.00.Current price is: $99.00.

Growth & Secretagogue Research

4.9

(210)

MOTS-C

Price range: $49.00 through $155.00

Metabolic Research

4.9

(238)

Latest

99.84%

PURITY

Variant

10 mg

Lot #

RT10-260101

Labeled

10 mg

Actual

13.6 mg

Tested

02/03/26

Compound Informations

Chemical and structural properties

MOLECULAR PROFILE

What Is GLP-3 (RT)?

Type Synthetic peptide

CAS Number 2381089-83-2

Molecular Weight 4,731 g/mol

Amino Acids 39

Fatty Acid Chain C20 diacid

🧊 STORAGE REQUIREMENTS

Stability Information

Avoid freeze/thaw cycles Protect from light Keep refrigerated

❄️ Lyophilized (powder) -20°C (24+ months)

💉 Reconstituted 2-8°C (~30 days)

Sources & References

Peer reviewed research

NEW ENGLAND JOURNAL OF MEDICINE

Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial

2023 • DOI: 10.1056/NEJMoa2301972

Jastreboff AM, et al.

THE LANCET

GLP-3 (RT) for People with Type 2 Diabetes — A Phase 2 Trial

2023

Rosenstock J, et al.

NATURE MEDICINE

GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease

2024

Sanyal AJ, et al.

LANCET DIABETES & ENDOCRINOLOGY

Effects of GLP-3 (RT) on Body Composition

2025

Coskun T, et al.

PUBMED CENTRAL

Triple Agonism Based Therapies for Obesity

2025

PUBMED CENTRAL

GLP-3 (RT) — A Game Changer in Obesity Pharmacotherapy

2025

PUBMED CENTRAL

Efficacy and Safety of GLP-3 (RT) — Systematic Review & Meta-Analysis

2024

ELI LILLY

TRIUMPH-4 Phase 3 Trial Results

2025

NATURE CELL DISCOVERY

Structural Analysis of Incretin Receptor Agonists

2024

PUBCHEM DATABASE

GLP-3 (RT) Compound Information

CLINICALTRIALS.GOV

GLP-3 (RT) Clinical Trials Registry

IMPORTANT RESEARCH NOTICE

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

0

Age Verification Required

You must be 21 years or older to access this website.

You must be 21 years or older to access this website. By continuing, you confirm that you are of legal age and are purchasing these products strictly for laboratory research purposes only. These products are not for human or veterinary use.

I confirm I am 21 years or older

I am purchasing strictly for laboratory research purposes only

I understand these products are not for human or veterinary use